Invitrogen, Cellartis collaborate on technology to track stem cell lines

New York, June 27 - Invitrogen Corp. and Cellartis AB announced they will collaborate on developing novel engineered human embryonic stem cell reporter lines.

These lines will, for the first time, provide scientists with a visual readout for tracking stem cell differentiation into different lineages and also enable scientists to study multiple genes involved in differentiation pathways, without having to sacrifice the cells, the companies said.

The work will use Invitrogen's platform technologies and expertise in molecular and cellular biology, labeling and detection and cell culture and Cellartis' expertise in deriving and growing human embryonic stem cell lines.

Financial terms were not disclosed.

Invitrogen is a Carlsbad, Calif., provider of products and services to support academic and government research institutions and pharmaceutical and biotech companies. Cellartis is a Gothenburg, Sweden, company engaged in research, development and manufacture of human embryonic stem cells and specialized functional cells derived from these cell lines.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.